Elizabeth S Kaled

Bosutinib Therapy in Patients With Chronic Myeloid Leukemia: Practical Considerations for Management of Side Effects

P. Ault, John Rose, PharmD, Lisa A. Nodzon, PhD, 2016, Journal of the advanced practitioner in oncology.

Ensuring optimal adherence to BCR-ABL1 tyrosine kinase inhibitor therapy for chronic myeloid leukemia

M. Welch, Elizabeth S Kaled, 2013 .

Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.

H. Kantarjian, J. Cortes, C. Koller, 2002, Leukemia research.

Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome.

H. Kantarjian, J. Cortes, W. Wierda, 2003, Blood.